» Articles » PMID: 10374087

Endocrine Abnormalities During the Follicular Phase in Women with Recurrent Spontaneous Abortion

Overview
Journal Hum Reprod
Date 1999 Jun 22
PMID 10374087
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The frequency of endocrine abnormalities during the follicular phase in non-pregnant women with a history of recurrent abortion was investigated in a case-control study. A total of 42 consecutive women with recurrent spontaneous abortion (three or more consecutive abortions, mean +/- SD: 3.9 +/- 1.1 range 3-8) with no parental chromosome rearrangement or uterine abnormality were studied during the early follicular phase under standardized conditions. Serum concentrations of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, androstenedione, testosterone, dehydroepiandro-stenedione, 17-OH-progesterone, oestradiol, progesterone and thyroid stimulating hormone (TSH) were measured by commercially available radioimmunoassays. Controls were 42 nulligravid females with tubal or male factor infertility without miscarriage. Mean (SD) concentrations of prolactin and androstenedione were 14.2 +/- 6.7 ng/ml versus 10.5 +/- 3.5 ng/ml (95% CI 0.8-6.1) and 2.3 +/- 0.9 ng/ml versus 1.7 +/- 0.6 ng/ml (95% CI 0.2-0.9) in the study and control groups respectively. The other endocrine parameters were comparable in both groups. Obesity [BMI weight (kg)/height (m2) > or = 25] was more prevalent (23 versus 5 women, P = 0.0001) in the study than the control group. Recurrent spontaneous abortion is associated with abnormalities in prolactin and androgen secretion during the follicular phase, suggesting an endocrine aetiology in this disorder. Reduction of body weight and correction of hyperprolactinaemia and of hyperandrogenism may reduce the rate of miscarriage in a subsequent pregnancy in these women.

Citing Articles

Androgens modulate endometrial function.

Yamagata K, Mizuno Y, Mizuno Y, Tamaru S, Kajihara T Med Mol Morphol. 2025; .

PMID: 40063300 DOI: 10.1007/s00795-025-00430-6.


Elevated levels of exogenous prolactin promote inflammation at the maternal-fetal interface via the JAK2/STAT5B signaling axis.

Williams A, Hossack D, Thompson N, Sim Y, Wilson C, Schuch V Front Immunol. 2025; 15:1496610.

PMID: 39763651 PMC: 11701216. DOI: 10.3389/fimmu.2024.1496610.


Pre-Conception Androgen Levels and Obstetric Outcomes in Polycystic Ovary Syndrome: A Single-Center Retrospective Study.

Orosz M, Borics F, Ratonyi D, Vida B, Csehely S, Jakab A Diagnostics (Basel). 2024; 14(19).

PMID: 39410647 PMC: 11476020. DOI: 10.3390/diagnostics14192241.


Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I.

Suker A, Li Y, Robson D, Marren A Aust N Z J Obstet Gynaecol. 2024; 64(5):432-444.

PMID: 38934264 PMC: 11660023. DOI: 10.1111/ajo.13821.


Decreased Expression of Placental Proteins in Recurrent Pregnancy Loss: Functional Relevance and Diagnostic Value.

Toth E, Gyorffy D, Posta M, Hupuczi P, Balogh A, Szalai G Int J Mol Sci. 2024; 25(3).

PMID: 38339143 PMC: 10855863. DOI: 10.3390/ijms25031865.